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 Developmental neurogenesis, the formation of neurons in utero, is tightly 
regulated by apoptosis, a form of programmed cell death. The pro-survival protein Mcl-1 
has been shown to be important for the survival of the developing nervous system 
through its ability to inhibit apoptosis. This dependency is poorly understood. Moreover, 
how Mcl-1 inhibits apoptosis in the developing nervous system is unknown. Here, 
conditional ablation of mcl-1 in the murine developing nervous system (Mcl-1 CKO) 
resulted in widespread death throughout the developing nervous system. Mcl-1 CKOs 
showed a progression of apoptosis that mirrors the progression of differentiation in the 
brainstem and spinal cord. Apoptosis was rescued by co-deleting pro-apoptotic Bax in 
Mcl-1 CKO mice, demonstrating that Mcl-1 promotes cell survival by blocking the 
activation of Bax. This work is the first to demonstrate widespread dependency on Mcl-1 
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1-1 Overview of early formation of the nervous system 
 
The complex tasks performed by the adult mammalian nervous system 
require many unique populations of cells, each with a specific locality, morphology, and 
gene expression profile. As such, developmental neurogenesis, the formation of the 
nervous system in an embryo, is tightly regulated to ensure proper postnatal functionality. 
The nervous system forms from the ectoderm shortly after gastrulation. Signaling from 
the notochord initiates the transformation of ectodermal cells to neuroectodermal cells. 
This results in a thickening known as the neural plate (Copp et al., 2003). In the mouse, 
neurulation, when the neural plate folds into the neural tube, begins at embryonic day 8 
(E8) of the 21-day gestation period, although primitive neural stem cells are present at 
E5.5-E7.5 (Copp et al., 2003).  
Neural stem cells are defined by three properties. First, they must be able to form 
neural tissue or be formed from neural tissue. Second, they must be able to self-renew, 
and third, they must be able to form other neural cells through asymmetric divisions 
(Gage, 2000). The early neural tube consists of Leukemia Inhibitory Factor (LIF)-
responsive primitive neural stem cells, known as neuroepithelial cells, that divide 
symmetrically to form more neural stem cells (Hitoshi et al., 2004; Tropepe et al., 2001). 
These cells divide to form the definitive neural stem cells, known as radial glial cells 
(RGCs). RGCs are characterized by their expression of the intermediate filament protein 
Nestin beginning at E7.5 and their responsiveness to Fibroblast growth factor-2 (Fgf2) 
beginning at E8.5 (Hitoshi et al., 2004; Kawaguchi et al., 2001; Tropepe et al., 1999). The 
2 
 
definitive neural stem cells give rise to the astrocytes, neurons and oligodendrocytes that 
populate the brain and spinal cord (Ramasamy et al., 2013).  
1-2 Developmental neurogenesis of the forebrain 
 
 The neocortex has served as the basic model for dorsal forebrain development. 
The cortex is comprised of six layers that form in an inside-out manner (Rakic, 1974). 
RGCs reside in the lumen of the neural tube that then becomes the ventricular zone but 
have processes that extend to the pial surface of the developing brain (Farkas & Huttner, 
2008). RGCs divide symmetrically to produce two RGCs or two neurons, or 
asymmetrically to form an RGC and a cell committed to differentiate. It is in this manner 
that RGCs produce the post-mitotic neurons of the brain without extinguishing the 
progenitor population. The differentiating cells migrate and form the three main cell types 
of the brain: neurons, astrocytes and oligodendrocytes (Ohtaka-Maruyama & Okado, 
2015).  
Excitatory glutamatergic neurons migrate radially up the cortex, using the RGC’s 
long processes to climb through the cortex. Inhibitory GABAergic neurons migrate 
tangentially from the ganglionic eminences to the cortex (Lavdas et al., 1999; Luhmann 
et al., 2015). The ganglionic eminences are a collection of three structures in the ventral 
telencephalon that protrude into the ventricular space (Figure 1-1). The lateral ganglionic 
eminence forms the striatum in the adult brain, and the medial ganglionic eminence forms 
pallidal structures in the adult brain and gives rise to cholinergic neurons. The caudal and 
medial ganglionic eminences produce the majority of cortical GABAergic interneurons 
(Turrero Garcia & Harwell, 2017). Neurogenesis in these regions varies, with 
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neurogenesis in the medial ganglionic eminence beginning at E9 and in the caudal 
ganglionic eminence at E12 (Miyoshi et al., 2007; Miyoshi et al., 2010).   
The process by which neural stem cells and progenitor cells, collectively known 
as neural precursor cells (NPCs), proliferate and differentiate is highly controlled. 
Neurogenesis in the cerebral cortex of the mouse brain occurs over 11 successive cell 


















Figure 1-1. The ganglionic eminences shown through coronal sections of the 
developing telencephalon. (A) The lateral ganglionic eminence (pink) and the medial 
ganglionic eminence (yellow) develop in the E10 forebrain. (B) By E12, the caudal 
ganglionic eminence (blue) is formed. Both the medial and caudal ganglionic eminence 
produce GABAergic interneurons that migrate tangentially into the developing cortex 











1-3 Developmental neurogenesis of the spinal cord 
 
 The patterning of the developing spinal cord is well characterized. Neurogenesis 
in the spinal cord begins at E9.5 and continues until E18.5 (Alaynick et al., 2011). The 
newly formed caudal neural tube becomes the spinal cord in the adult. As with the 
forebrain, development is tightly controlled, with several axes of development including 
rostral/caudal, dorsal/ventral and medial/lateral (Figure 1-2) (Gouti et al, 2015). The 
rostral/caudal axis is controlled caudally by gradients of Fgf8 and wingless-related 
integration site (Wnt), which maintain cells in a more stem-like state and cause the 
elongation of the spinal cord (Wilson et al., 2009). The rostral axis is controlled by 
gradients of retinoic acid (RA), which is secreted by the somites that line the developing 
neural tube and is associated with a reduction in body elongation (Olivera-Martinez et al., 
2012). Exposure to RA causes cells to transition to a more lineage-restricted NPC fate 
(Gouti et al., 2015). On the dorsal/ventral axis, two opposing morphogen gradients cause 
the patterning of the spinal cord. The dorsal aspect of patterning is driven by gradients of 
bone morphogenetic protein (Bmp), whereas the ventral aspect is patterned by gradients 
of sonic hedgehog (Shh) (Simões-Costa & Bronner, 2015). These morphogens cause the 
expression of many different transcription factors along the dorsal/ventral axis that 
ultimately result in 12 unique regions (Gouti et al., 2015). The medial/lateral axis of the 
spinal cord varies based on state of differentiation, with the medial portion containing 
proliferating NPCs and the lateral portion containing differentiated cells. NPCs reside in 
the medial ventricular zone, which lines the central canal. As the NPCs differentiate, they 
migrate laterally (Ulloa & Briscoe, 2007). The proper formation of the spinal cord and 
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brain require regulation of cell numbers. A critical regulating feature is apoptosis, a type 
of programmed cell death.  
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Figure 1-2. Spinal cord neurogenesis is controlled by morphogen gradients in the 
dorsal/ventral, medial/lateral and rostral/caudal axes. (A) The rostral axis is controlled by 
gradients of RA and the caudal axis is controlled by gradients of Fgf and Wnt. 
Differentiation of NPCs begins in the rostral spinal cord and progresses caudally. (B) The 
dorsal axis is controlled by gradients of Bmp and the ventral axis is controlled by 
gradients of Shh. Differentiation of NPCs begins in the ventral spinal cord and 
progressing dorsally (C) As NPCs differentiate, they migrate laterally from the midline in 






































1-4 Apoptosis  
 
The first identified form of regulated cell death was apoptosis. Apoptosis was 
originally classified based on the laddering of DNA and its morphology: shrinking of the 
cytoplasm, membrane blebbing, condensed nuclei, and nuclear fragmentation. Through a 
microscope, these apoptotic cells appear as small clusters of cell fragments (Kerr et al., 
1972). There are two main signals by which apoptosis is activated: extrinsic signals and 
intrinsic signals. The extrinsic apoptotic pathway is activated via external environmental 
cues through specific death receptor activation on the surface of the cell, whereas 
intrinsic apoptosis results from intracellular stresses that do not activate the death 
receptors responsible for extrinsic apoptosis (Galluzzi et al., 2018). Both pathways 
converge on the activation of caspases. Although the result of both the extrinsic and 
intrinsic apoptotic pathways is the same, the process by which the cell gets to the final 
executioner caspase activation is different. The intrinsic apoptotic pathway plays a key 
role in the developing nervous system (Yuan & Yankner, 2000); therefore, for the 




  Caspases are a family of cysteine-aspartic acid proteases normally found residing 
in an inactive form, where they are known as pro-Caspases. Three varieties of caspases 
exist, inflammatory caspases, initiator caspases and executioner caspases. Initiator and 
executioner caspases are responsible for the amplification and execution of the apoptotic 
cascade, respectively (Shalini et al., 2015). Initiator caspases such as Caspase 8 and 9 
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contain Death Effector Domains (DEDs) or Caspase-Recruitment Domains (CARDs) that 
are used to form complexes with other proteins that cleave and activate these caspases. 
Once activated, initiator caspases cleave and activate the executioner caspases such as 
Caspase 3 and 7, which are responsible for the dismantling of the cell (Thornberry & 
Lazebnik, 1998). The activation of Caspase 3 and Caspase 7 is the last step of the 
intrinsic apoptotic pathway. Caspase 3 activation is essential for apoptosis and results in 
DNA fragmentation, nuclear condensation and the proteolysis of many protein targets. 
Caspase 7 has few proteolytic targets and has a minor role in apoptosis compared to 
Caspase 3, though it is essential for cell detachment (Slee et al., 2001; Walsh et al., 2008; 
Brentnall et al., 2013). In combination with nuclear condensation, activation of Caspase 3 
(AC3) is considered a marker for apoptosis (Boatright & Salvesen, 2003).  
 
1-4-2 The mechanism of intrinsic apoptosis  
 
Intrinsic apoptosis can result from several different stress signals such as DNA 
damage, growth factor deprivation and cell cycle arrest (Galluzzi et al., 2018). The 
central mechanism behind intrinsic apoptosis is mitochondrial outer membrane 
permeabilization (MOMP). MOMP serves two purposes in cell death. Firstly, MOMP 
causes a loss in mitochondrial membrane potential, leading to a loss in energy production. 
Secondly, MOMP results in the release of cytochrome c from the mitochondrial 
intermembrane space (Liu et al., 1996). Once released into the cytosol, cytochrome c 
binds apoptotic protease activating factor 1 (APAF 1) and pro-Caspase 9, to form a 
structure known as the apoptosome (Li et al., 1997). This apoptosome cleaves pro-
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Caspase 9 into active Caspase 9, which in turn activates the executioner Caspase 3 and 
Caspase 7 (Li et al., 1997). Also released during MOMP are pro-apoptotic second 
mitochondrial activator of caspases (SMAC; also known as Diablo) (Du et al., 2000; 
Verhagen et al., 2000) and anti-apoptotic x-linked inhibitor of apoptosis (XIAP) (Roy et 
al., 1997). XIAP prevents apoptosis through the inhibition of Caspase activity and has 
been shown to inhibit apoptosis due to UV light exposure, chemotaxic drugs and 
activation of tumour necrosis factor (Duckett et al., 1998; Eckelman et al, 2006). SMAC 
promotes apoptosis through direct inhibition of XIAP (Du et al., 2000) 
 
1-4-3 Apoptosis in the developing nervous system 
 
 
  Apoptosis is essential for proper nervous system development. In the central and 
peripheral nervous system, up to 50% of cells die of apoptosis (Dekkers et al., 2013). 
Prenatally, apoptosis occurs during neural tube closure, in the developing hindbrain, optic 
invaginations and proliferating precursor populations of the cortex. Apoptosis also occurs 
as post-mitotic neurons form synaptic connections (Copp et al., 2003; Yeo & Gautier, 
2004). Apoptotic cell death continues postnatally in many cell populations, including the 
neocortex, hippocampus and brainstem (White & Barone, 2001). From initiation to 
clearance, apoptosis occurs on a time scale of a few hours (Bursch et al., 1990); therefore, 
despite the amount of apoptosis that occurs in the nervous system, the rapid progression 
means that only 2-3% of cells are undergoing apoptosis at any one point in time (White & 
Barone, 2001).  
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1-5 The Bcl-2 family of proteins  
 
 In the intrinsic apoptotic pathway, whether a cell lives or undergoes apoptosis is 
determined by the B cell lymphoma-2 (Bcl-2) family of proteins. This family of proteins 
is named after the founding member, Bcl-2, a potent anti-apoptotic protein (Tsujimoto et 
al., 1985; Vaux et al., 1988). The Bcl-2 family is characterized by Bcl-2 Homology (BH) 
domains. These domains interact with each other, and these interactions result in the 
activation or repression of the pro-apoptotic and anti-apoptotic properties of the Bcl-2 
family (Youle & Strasser, 2008). There are three main categories of Bcl-2 family 
members: anti-apoptotic, pro-apoptotic BH3-only and pro-apoptotic effector proteins 
(Figure 1-3).  
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Figure 1-3. The Bcl-2 family of proteins. Diagrams of Bcl-2 family members 
demonstrating the BH1-4 domains they contain. Anti-apoptotic proteins oppose the 
activity of pro-apoptotic effector proteins, sensitizers and direct-activators. Many of the 
Bcl-2 family members have the ability to interact with membranes throughout the cell 
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The pro-apoptotic BH3-only proteins act as sensors throughout the cell, each 
specializing in the detection of different death signals. Two types of BH3-only proteins 
exist, direct activators and sensitizers. Direct activators such as Bim can directly activate 
the pro-apoptotic effector proteins (Gavathiotis et al., 2010). Sensitizers like Noxa 
function to displace and free direct activators that have been sequestered by anti-
apoptotic proteins (Figure 1-4) (Willis et al., 2007). 
Effector proteins, Bax and Bak, are responsible for forming multimer complexes 
with themselves that form pores in the mitochondrial outer membrane (Chittenden et al., 
1995; Oltval et al., 1993). These are the pores through which cytochrome c enters the 
cytosol to continue the intrinsic apoptotic cascade. These effector proteins are activated 
by direct activator BH3-only proteins. The anti-apoptotic proteins bind both BH3-only 
and effector proteins to prevent apoptosis from occurring. An outline of the intrinsic 
apoptotic cascade can be seen in Figure 1-5 (Youle & Strasser, 2008).  
 Members of the Bcl-2 family show both selectivity and redundancy in their 
propensity to bind each other. The BH3-only direct activator proteins PUMA, Bid, and 
Bim bind anti-apoptotic proteins Bcl-2, Bcl-XL, Mcl-1 and Bcl-w promiscuously. Bad 
binds Bcl-2, Bcl-XL and Bcl-w, but not Mcl-1. Noxa is specific for Mcl-1 (Chen et al., 
2005). Pro-apoptotic effector protein Bax has been shown to bind all anti-apoptotic 
proteins, whereas Bak has been shown to bind Bcl-XL, Mcl-1 and A1 (Czabotar et al., 
2014). BH3-only direct activator proteins such as Bid and Bim bind Bax and Bak 
directly, whereas sensitizers such as Bad do not bind Bax and Bak directly (Letai et al., 
2002). A summary of interactions is diagramed in Figure 1-6.  
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Figure 1-4. BH3-only proteins can act as sensitizers or direct-activators. Direct-activators 
are inhibited by the anti-apoptotic Bcl-2 family members and activate Bax/Bak. 
Sensitizers inhibit the anti-apoptotic Bcl-2 members from inhibiting direct-activators or 












Figure 1-5. The intrinsic apoptotic pathway. Intracellular stresses activate the pro-
apoptotic BH3-only proteins. In turn, the BH3-only proteins activate Bax/Bak, resulting 
in MOMP. Anti-apoptotic Bcl-2 family members such as Mcl-1 inhibit both BH3-only 
proteins and Bax/Bak. The release of cytochrome c and APAF-1 causes the formation of 
the apoptosome, which activates Caspase-9, which in turn, activates Caspase 3 to 

























Figure 1-6. Interactions between the pro-apoptotic and anti-apoptotic Bcl-2 family 
members. Mcl-1 has been shown to interact with pro-apoptotic effector proteins Bax and 
Bak, BH3-only sensitizers (light blue) and BH3-only direct activators (dark blue) 
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1-5-1 The anti-apoptotic Bcl-2 family members in the nervous system 
 
 Knock-out and germline deletion models have shown that the Bcl-2 family 
members have unique and overlapping roles. Tissue specific knock-out of a gene of 
interest is possible via Cre/lox recombination. The gene of interest is flanked (floxed) by 
sequences known as loxP sites. These sites are recognized by the enzyme Cre 
recombinase, which is genetically inserted under a tissue-specific promoter, and Cre 
excises sequences between the loxP sites upon its translation. The tissue-specific 
promoter driving Cre expression results in the tissue-specific deletion of the protein of 
interest (Sauer, 1998).   
Bcl-2 deficient mice survive to six months postnatal, but prematurely grey by six 
weeks and develop polycystic kidney disease (Veis et al., 1993). Bcl-2 is not required for 
the survival of the developing nervous system but has a postnatal role in the survival of 
motor neurons, sensory neurons and sympathetic neurons (Michaelidis et al., 1996). Bcl-x 
germline knock-out mice die by E14 due to erythroid progenitor cell death and neuronal 
cell death (Motoyama et al., 1995). When bcl-x is conditionally knocked-out in the 
nervous system using Nestin:Cre-mediated deletion, cell death begins at E11 and travels 
across the spinal cord following the progression of neuronal differentiation. Apoptosis 
peaks in the nervous system at E13 and mice are embryonic lethal by E18. Further 
analysis shows that cells of the spinal cord become dependent on Bcl-xL within 24 hours 
of initiating differentiation (Fogarty et al., 2016). Germline co-deletion of bcl-x and bax 
rescued most of the apoptosis that occurred in the nervous system of bcl-x null mice alone 
at E12 but did not rescue embryonic lethality and did not rescue the increased apoptosis 
seen in bcl-x null telencephalon-derived in vitro cultures (Shindler et al., 1997). 
24 
 
Nestin:Cre-mediated deletion of bcl-x and co-deletion of bax rescued apoptosis 
associated with bcl-x deletion alone in the nervous system (Fogarty et al., 2018). Bcl-xL 
has also been shown to be important in neurons of the upper layers of the cortex as well 
as the CA1-CA3 regions of the hippocampus (Nakamura et al., 2016). Deletion of bcl-x 
in these populations results in risk-taking behaviour, self injury and cognitive deficits in 
mice (Nakamura et al., 2016). Bcl-xL is also an important survival factor in rod 
photoreceptors, retinal ganglion cells and catecholaminergic neurons of the substantia 
nigra (Harder et al., 2012; Savitt et al., 2005; Zheng et al., 2006). Not all Bcl-2 family 
members have been implicated in nervous system development.  For example, Bcl-w 
(Print et al., 1998) and A1 (Schenk et al., 2017) have not been found to play a significant 
role in the developing nervous system. 
 
1-5-2 BH3-only proteins in the nervous system 
 
Germline deletion of BH3-only proteins Bid, Bad or multi-domain pro-apoptotic 
Bak resulted in no change in cell death of superior cervical ganglion neurons upon 
trophic factor deprivation (Putcha et al., 2002). Germline deletion of Bim provided partial 
rescue of apoptosis in superior cervical ganglia and in the central nervous system upon 
trophic factor deprivation, implicating Bim as an important BH3-only protein in the 
nervous system (Putcha et al., 2001).  Triple knock-out of Bim, Bid and PUMA resulted 
in similar defects in mice deficient in Bax and Bak such as imperforate vaginas and 
persistent interdigital webbing (Ren et al., 2010). Moreover, these mice were resistant to 
ionizing radiation exposure in adult cerebellar granule neurons (Ren et al., 2010). 
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Deletion of PUMA alone reduced apoptosis in irradiated cerebellar granulated neurons, 
but co-deletion of Bim and Bid was required to prevent apoptosis all together (Ren et al., 
2010). Single deletion of Bad (Ranger et al., 2003) or Bid (Leonard et al., 2001) does not 
appear to have any neurological consequences.  
 
1-5-3 Bax and Bak in the nervous system 
 
The role of Bax and Bak in the nervous system has been studied; however, Bax 
has been studied more extensively than Bak. Bax expression has been detected in the 
primitive nervous system as early as E6, whereas expression of Bak does not occur in the 
nervous system until E12 (Krajewska et al., 2002).  Bax deficient (Bax-/-; BaxNull) male 
mice are sterile due to defects in sperm maturation, but otherwise survive (Knudson et al., 
1995). BaxNull mice show increased neuronal numbers in superior cervical ganglia and 
the facial nuclei. In addition, sympathetic and facial motor neurons were resistant to 
apoptotic stimuli (Deckwerth et al., 1996). BaxNull mice also show increased cell 
numbers and reduced cell death in the dentate gyrus of the adult mouse hippocampus 
(Sun et al., 2004). Between E11.5 and postnatal day 1, deletion of Bax resulted in 
decreased cell death in spinal cord motor neuron pools, peripheral ganglia, the 
cerebellum, hippocampus, retina and trigeminal brainstem nuclear complex (White et al., 
1998). Bak and Bax germline co-deletion (Bax-/-Bak-/-) is not embryonic lethal in mice, 
but many pups die shortly after birth and show classic signs of absent developmental 
apoptosis such as imperforate vaginas and webbed digits (Lindsten et al., 2000). Bax-/-
Bak-/- showed circling behaviour and are unresponsive to auditory stimulation. Histology 
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revealed excessive numbers of small, chromatin dense cells in the regions surrounding 
the ventricles of the brain (Lindsten et al., 2000). Bax-/-Bak-/- adult mice show excessive 
numbers of NPCs as well as immature neurons and glial cells in the brain demonstrating 
that effector proteins are responsible for reducing the population of NPCs in the brain. 
These cells were resistant to apoptotic stimuli; however, adult neurons were not resistant 
to death due to excitotoxicity (Lindsten et al., 2003). Bak-/- mice show no gross defects 
(Lindsten et al., 2000). These data demonstrate that Bax is the main pro-apoptotic 
effector member of the Bcl-2 family of proteins in the nervous system. Although Bax is 
important in regulating cell numbers in the developing brain, no research has elucidated 
how Bax activation is regulated in the developing nervous system.  
 
1-6 Myeloid cell leukemia-1 (Mcl-1) 
 
 Mcl-1 is an anti-apoptotic member of the Bcl-2 family of proteins. It was 
originally discovered as a protein that was upregulated in response to myeloid cell 
differentiation in the ML-1 human myeloid leukemia cell line (Kozopas et al., 1993). 
Germline deletion of Mcl-1 is peri-implantation lethal at E3.5-E4 due to trophectoderm 
differentiation defects, making the study of Mcl-1 in other tissues challenging 
(Rinkenberger et al., 2000). The development of a floxed mcl-1 mouse allowed insight 
into how Mcl-1 functions in different tissues via Cre/lox-mediated deletion. Conditional 
ablation of mcl-1 in murine lymphocytes showed that both B and T lymphocytes are 
dependent on Mcl-1 for survival (Opferman et al., 2003). Conditional ablation of mcl-1 in 
hematopoietic stem cells resulted in the destruction of bone marrow cell populations 
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(Opferman et al., 2005). Deletion of mcl-1 in liver cells did not impact cell survival 
(Opferman et al., 2005).  
 Mcl-1 is unique among the anti-apoptotic proteins for many reasons.  Firstly, Mcl-
1 has only BH domains 1-3, unlike the other anti-apoptotic proteins, which have BH 
domains 1-4. Mcl-1 also has an elongated N-terminus. The N-terminus has many 
phosphorylation and ubiquitination sites. It also has many sequences known as PEST 
(proline, aspartic acid, serine and threonine) sequences. These PEST sequences make 
proteins more labile to degradation (Rechsteiner & Rogers, 1996). Overall, the PEST 
sequences, as well as the number of phosphorylation and ubiquitination sites found in the 
N-terminal region of Mcl-1 makes it highly modifiable with a short half-life compared to 
other Bcl-2 family members (Thomas et al., 2010; Yang et al., 1995).  
 
1-7 Mcl-1 and neurogenesis  
 
 Conditional deletion of mcl-1 in NPCs of the developing telencephalon with the 
use of either a FoxG1 or Nestin-mediated Cre (Mcl-1 CKO), revealed that Mcl-1 is an 
important anti-apoptotic factor in NPCs. Deletion of mcl-1 results in massive apoptosis in 
the developing brain. This apoptosis extends throughout the course of neuronal 
differentiation in Nestin+ NPCs, Doublecortin+ migrating neuroblasts, and Tuj1+ newly-
born neurons in the developing forebrain. This massive apoptosis resulted in reduced 
cortical plate formation and embryonic lethality by E15.5-E16 in both deletion models. 
Further investigation using conditional deletion of mcl-1 in cortical progenitors in vitro 
showed that the dependency on Mcl-1 is cell autonomous, whereas deletion of mcl-1 in 
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cortical neurons did not result in increased cell death, but rather increased sensitivity to 
DNA damage (Arbour et al., 2008). mcl-1 deletion in adult neurons, however, does not 
result in apoptosis without further death stimuli. Alternatively, it results in increased 
autophagy. Nutrient deprivation was shown to result in the endogenous degradation of 
Mcl-1, causing autophagy through de-repression of Beclin-1 (Germain et al., 2011). Mcl-
1 has also been shown to be expressed in adult NPCs, and deletion of Mcl-1 in adult 
NPCs in vitro resulted in a doubling of apoptosis. Overexpression of Mcl-1 in adult NPCs 
in vitro reduced apoptosis (Malone et al., 2012). The results from these studies suggest 
that as NPCs differentiate, their dependency on Mcl-1 changes. NPCs, both embryonic 
and adult, depend on Mcl-1’s anti-apoptotic properties, whereas adult neurons depend on 
Mcl-1 for its anti-autophagic properties.  A third role for Mcl-1 in cell cycle exit of NPCs 
has been proposed. The potential for Mcl-1 to be involved in cell cycle dynamics has 
been discussed previously, but whether it impacted the cell cycle of neural cells was 
unknown. Overexpression studies have shown that Mcl-1 plays a role in the terminal 
mitosis of NPCs (Hasan et al., 2013).  
 Further investigation has shown that although the literature has suggested that 
Mcl-1 dependency and Bcl-xL dependency are sequential, NPCs are dependent on both 
Mcl-1 and Bcl-xL. Deletion of one allele of bcl-x in NPCs deficient in mcl-1 will 
exacerbate the increase in cell death (Fogarty et al., 2018).  
 Although research has investigated the role of Mcl-1 in nervous system 
development, no research has determined if Mcl-1 is important for the survival of the 
nervous system when it initially forms during, and shortly after, neurulation. The pro-
apoptotic effector protein that Mcl-1 inhibits in the developing nervous system is also 
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unknown. One candidate is Bax, which has been shown to be inhibited by Mcl-1, though 
this has not been shown in the nervous system (Germain et al., 2008).  
1-8 Hypothesis and Aims 
 
The role of Mcl-1 in the early developing nervous system has not been fully 
characterized. Further, the relationship between anti-apoptotic Mcl-1 and pro-apoptotic 
effector activation has not been investigated, and therefore, the mechanism by which 
Mcl-1 inhibits apoptosis in the developing nervous system is yet to be elucidated. 
 I hypothesize that cells throughout the developing nervous system are dependent 
on Mcl-1 for survival, and this dependency is largely due to either the direct or indirect 
Mcl-1 inhibiting pro-apoptotic Bax (Figure 1-7). I will investigate my hypothesis using 
the following specific aims: 
• Specific aim 1: Characterize the cell death in the developing nervous system of 
the Mcl-1 CKO. 
• Specific aim 2: Determine the mechanism by which Mcl-1 inhibits apoptosis is 
the developing nervous system.  
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Figure 1-7. Hypothesis.  (A) In the healthy condition and in the absence of apoptotic 
stimulation, Mcl-1 prevents apoptosis by inhibiting both BH3-only proteins and pro-
apoptotic effector proteins. (B) The Nestin-mediated conditional deletion of Mcl-1 
results in increased apoptosis in the developing nervous system as BH3-only proteins 
are no longer inhibited and can activate the pro-apoptotic effector protein Bax. (C) 
Co-deletion of Mcl-1 and Bax is hypothesized to rescue the apoptosis associated with 
the Mcl-1CKO alone as Mcl-1 inhibits apoptosis in the developing nervous system 














(B) Mcl-1 CKO (C) Mcl-1 CKO/BaxNull 





2-1 Transgenic mouse line husbandry 
 
Memorial University of Newfoundland’s Animal Care Committee approved all 
experiments, which adhere to the Guidelines of the Canadian Council on Animal Care. 
Mice were housed on a 12-hour light/dark cycle and had access to food and water ad 
libitum. Transgenic mouse lines outlined in Table 2.1 below, were maintained on a 
C57Bl/6J background.   
 
Table 2.1: Sources of transgenic mouse lines used in experiments. 
Transgenic mouse 
line 
Abbreviation Provided by Reference 
mcl-1 floxed (mcl-1(f/f)) In house 
(Opferman et al., 
2003) 




(Knudson et al., 
1995) 




(Takeuchi et al., 
2005) 
nestin mediated cre (nes:cre+/-) In house 
(Bérubé et al., 
2005) 
f= floxed, - = null, + = wild type  
mcl-1(f/f) mice were crossed onto the bax (-/-) and bax (f/f) transgenic lines of mice to 
generate an mcl-1(f/f): bax (-/f) transgenic line. Due to sterility of both mcl-1(f/f) (Okamoto et 
al., 2014) and bax(-/-) (Knudson et al., 1995)  males, only male mice with mcl-1(+/f):bax(+/-) 
or mcl-1(+/f):bax(f/f) were bred with female mice who could be one of many mcl-1 or bax 
genetic combinations. For examples of genetic crosses and expected outcomes, see 
Appendix A.  
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2-2 Timed pregnancies  
 
Male and female mice were placed in the same cage for a maximum of three days. 
Females were weighed at breeding. Twice daily, a metal probe was used to detect the 
presence of a white plug in the vagina of the female mouse. The presence of the plug was 
taken as embryonic day 0.5. Upon discovery of a plug, mice were separated, and the 
female was weighed between E9 and E11. Only mice that had a plug and steady weight-
gain of at least three grams were assumed pregnant. 
2-3 Tissue collection, cryo-protection 
 
 Mice were euthanized with an intraperitoneal injection of 300 µl of sodium 
pentobarbital (Euthanyl, 240 mg/ml, CDMV, QC, CA) followed by cervical dislocation. 
Post-euthanasia, embryos were removed. Embryos were collected at E9, E10 and E11. 
Sex of the embryos was not determined and both sexes were included and analyzed as a 
single group. For cryo-sectioning, brains and spinal cords were dissected under a Stemi 
2000-C Stereo Microscope (Carl Zeiss Microscopy, LLC, USA). Embryos were then 
fixed in 4% v/v paraformaldehyde in phosphate buffered saline (1XPBS; 137 mM NaCl, 
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4), pH 7.4 overnight at 4℃. The 
following day, embryos were cryoprotected in a 30% w/v sucrose solution in 1XPBS 
until the embryo sank (approximately 24 hours). Next, tissue was further dissected into 
forebrain, brainstem, and three spinal cord sections, wicked free of residual moisture and 
placed in Tissue-Tek® O.C.T. compound embedding medium (Sakura Finetek, 4583, 
CA, USA). Embedded tissue was frozen in isopentane cooled by dry ice. Tissue was 
stored long-term at -80℃. 
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2-4 Cryo-sectioning of tissue 
 
 Embedded tissue was sectioned into 14µm thick sections using a Micron HM 520 
Cryostat (8243-30-1015, GMI, MN, USA). Sections were collected onto Superfrost Plus 
Microscope Slides (12-550-15, Fisher Scientific, PA, USA). Serial sections were 
collected across 6 slides each and after the sixth slide, four sections were discarded. Thus, 
sections on a given slide represented anatomical regions 140 µm (10 sections) apart. One 
slide per set was saved for staining using cresyl violet for general histology and 
landmarking purpose (section 2-7 Cresyl violet staining). After sectioning, slides were 
stored at -80ºC.   
2-5 Genotyping 
 
 Adult transgenic mice were genotyped to identify the transgenic make-up of a 
given mouse. Prior to weaning, all mice received an ear-tag that gave each mouse a 
numerical identity. A small piece of the tail tip was collected for genotyping. All 
transgenic embryos were genotyped post-dissection. While dissecting transgenic 
embryos, forelimbs were removed and divided into two microcentrifuge tubes for 
genotyping. One sample was frozen at -20ºC as a back up sample and one was used for 
genotyping. After tissue collection, processing of tissue and genotyping was identical for 
both embryonic and adult tissue. DNA extraction was carried out using a modified 
protocol of the REDExtract-N-Amp™ Tissue PCR Kit (XNAT-100RXN, Sigma-Aldrich 
Co. LLC, MO, USA). Tissue was digested overnight at 55ºC on a heat block in 70 µl of 
“Extraction Buffer” and 12 µl of “Tissue Prep”. The following day, samples were 
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vortexed vigorously and heated to 95ºC for 3 minutes before the addition of 70 µl 
“Neutralization Buffer”.  
 Genotyping for mcl-1, bax, and cre was carried out via Polymerase Chain 
Reaction (PCR) using OneTaq DNA Polymerase (M0480L, New England Biolabs, Inc., 
MA, USA). Primers and product sizes used for PCR are outlined in Table 2.2, reaction 
buffer recipes for each gene are outlined in Table 2.3, and the DNA Engine Peltier 
Thermal Cycler (ALD1244, BioRad, CA, USA) parameters are outlined in Table 2.4, 
below. Post-amplification, samples were loaded with DNA loading buffer (30% Glycerol, 
1 mM EDTA; pH 8.0, 0.06% bromophenol blue (BPB)) and run on a 2% UltraPure™ 
Agarose gel (16500-500, Invitrogen, CA, USA) in TAE (40 mM Tris-acetate, 1 mM 
EDTA) with ethidium bromide (15585011, Invitrogen, CA, USA) at 120 V using a 
BioRad PowerPac™ Basic Power Supply (1645050, BioRad, CA, USA) until positive 
control bands were resolved, which were visualized using an ultraviolet transilluminator.  
Table 2.2: Genotyping primer sets and product sizes. 





6 Mcl-1 5’-GCAGTACAGGTTCAAGCCGATG-3’ 
Wildtype:360bp 
Floxed: 400bp 7 Mcl-1 5’-CTGAGAGTTGTACCGGACAA-3’ 
bax 
floxed 
Baxf FOR 5’-GAATGCCAAAAGCAAACAGACC-3’ Wildtype:244bp 








CRE-3B 5’-TGACCAGAGTCATCCTTAGCG-3’ Presence:700bp 
No cre: no 




Table 2.3: PCR reaction buffer components for genotyping. 
 
Volume per reaction (µl) 
mcl-1 floxed bax floxed bax Null cre 
5X OneTaq Reaction 
Buffer 
10 10 10 10 
Primers (2.5 µM) 
6 Mcl-1 5 FOR 5 Bax1 10 3B 4 




dNTPs (1.25 mM) 8 8 8 8 
H2O 17.75 17.75 7.75 21.75 
OneTaq DNA 
Polymerase 
0.25 0.25 0.25 0.25 
DNA 4 2 4 2 
 
Table 2.4: Thermal cycler parameter for genotyping PCRs. 
Step mcl-1 floxed bax floxed 
1 94ºC 5.0 min  94ºC 3.0 min  
2 94ºC 1.0 min Steps 2-
4 
94ºC 30 sec Steps 2-4 
3 56ºC 1.0 min X 30 68ºC 1.0 min X 35 
4 72ºC 1.0 min  72ºC 1.0 min  
5 72ºC 1.0 min  72ºC 2.0 min  
6 10ºC Hold  10ºC Hold  
 bax Null cre 
1 94ºC 5.0 min  94ºC 2.0 min  
2 94ºC 1.0 min Steps 2-
4 
94ºC 1.0 min Steps 2-4 
3 55ºC 1.0 min X 30 56ºC 1.0 min X 30 
4 72ºC 1.0 min  72ºC 1.5 min  
5 72ºC 3.0 min  72ºC 5.0 min  




 All washes were at room temperature with shaking on a benchtop rotator unless 
stated otherwise. Slides were taken directly from -80ºC and placed on 37ºC slide warmer 
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for 20 minutes. While warming, a Dako Pen (S2002, Dako Denmark, Denmark) was used 
to draw a hydrophobic barrier around sections of the slide.  Slides were then washed in 
1XPBS twice for 5 minutes. After, slides were placed in a humidity chamber. Active 
Caspase 3 (AC3) rabbit IgG monoclonal primary antibody solution in 1XPBS ([1:400], 
559565, BD-Pharmingen, CA, USA) was then applied to the slide. The container was 
sealed overnight at room temperature without shaking. The following day, slides were 
washed three times in 1XPBS, placed in a humidity chamber and incubated with 
secondary donkey anti-rabbit IgG (H+L) AlexaFluor 488 nm antibody solution ([1:200], 
A21206, Invitrogen, CA, USA) for one hour at room temperature in the dark. Following 
secondary antibody application, all remaining procedures were carried out in opaque 
containers to prevent photo-bleaching of the secondary antibody fluorochromes. Slides 
were washed three times in 1XPBS and then stained in 40 µg/ml Bisbenzimide H33258 
to stain nuclei (Hoechst 33258; B1155, Sigma-Aldrich Inc, MO, USA) in 1XPBS for 2 
minutes at room temperature. Slides were then washed twice in 1XPBS and coverslipped 
with 3:1 1XPBS:Glycerol as a mounting media and Fisherbrand Microscope Cover Glass 
(12545C, Fisher Scientific, NH, USA). Edges of the coverslips were sealed using nail 
polish. Slides were stored at -20ºC.  
2-7 Cresyl violet staining 
 
One slide (5A, 10A, etc.) from each set of sectioned tissue was stained using 
cresyl violet for histology. Unless otherwise stated, all incubations occurred at room 
temperature without shaking in a fume hood. Slides were heated at 37ºC for 20 minutes 
followed by incubation in 0.1% w/v cresyl violet in water for 8-12 minutes. Post-
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incubation, slides were washed for 5 minutes in water to remove excess stain. Tissue was 
then dehydrated by submerging in increasing concentrations of ethanol for 30 seconds at 
each concentration (50%, 75%, 90%, 95%, and 3 times in 100% v/v ethanol in water). 
Next, slides were placed in isopropanol for 30 seconds, followed by two washes in 
toluene for 1 minute each. Slides were coverslipped using Permount® (SP15-500, Fisher 
Chemical, NJ, USA) and Fisherbrand Microscope Cover Glass (12545C, Fisher 
Scientific, NH, USA). After coverslipping, slides were left in the fume hood overnight to 
dry. 
2-8 In vitro neurosphere cell culturing 
 
Timed pregnant females were euthanized by a lethal injection of sodium 
pentobarbitol (Euthanyl, 240 mg/ml, CDMV, QC, CA) followed by cervical dislocation. 
Embryo forebrains were removed and dissected in ice-cold Hanks’ Balanced Salt 
Solution (14065-056, Gibco, NY, USA; pH 7.4). The ganglionic eminence was isolated 
and triturated gently in 37ºC stem cell media (see table 2.5) 30-40 times, until 
dissociated. Cells were then counted with a hemocytometer using 0.4% Trypan Blue 
(15250-061, Gibco, NY, USA). 3.3x105 cells were plated in 3 ml of 37ºC stem cell 
media. Cells were cultured at 37ºC with 5% CO2 for 3 days in a Forma Series II Water 
Jacket CO2 Incubator (Thermo Fisher Scientific, 3110, OH, USA). After 3 days, 
neurospheres were used for experiments or differentiated. To differentiate neurospheres, 
20-30 neurospheres between 100-150 µm in diameter were individually plucked using a 
pipette and placed in Lab-Tek 8 well Chamber Slides (177402, Thermo Scientific Nunc, 
NY, USA) containing 400 µl Differentiation Media (Table 2.6). Slides were pre-coated 
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with 0.0015% Poly-L-ornithine (P4957, Sigma Life Sciences, MO, USA) in sterile, 
distilled water for 1 hour at room temperature. Cells were incubated in the same 
conditions as the neurospheres (37ºC, 5% CO2) for 1, 3 or 7 days.  
Table 2.5: Stem cell media components for in vitro culturing. 
Reagent Concentration Source 
Dulbecco’s Modified Eagle Medium 
Nutrient Mixture F-12 (Ham) 
(DMEM/F12) (1:1) 
[+] L-Glutamine 
[+] 15 mM HEPES 
Base 11330-032, Gibco, NY, 
USA 
D-(+)-Glucose 5.85 mg/ml G7528-250G, Sigma, 
MO, USA 
l-glutamine 1.95 mM 25030081, Invitrogen, 
CA, USA 
Pen Strep (Penicillin Streptomycin) 48.7 units/ml 15140, Gibco, NY, 
USA 
Insulin 24.4 µg/ml I-5500-250MG, Sigma, 
MO, USA 
Apotransferrin 97.4 µg/ml 11096-37-0, Sigma, 
MO, USA 
Progesterone 0.0194 nM  
 
P8783-1G, Fisher, NY, 
USA 
Putrescine 9.36 µg/ml P5780-5G, Sigma, MO, 
USA 
Selenium 2.92 nM S5261-10G, Sigma, 
MO, USA 
Fungizone 12.1 ng/ml 15290018, Invitrogen, 
CA, USA 
Heparin 1.95 µg/ml H3149-50KU, Sigma, 
MO, USA 








Table 2.6: Differentiation media components for in vitro culturing. 
Reagent Concentration Source 
Neurobasal® Media 
[-] L-Glutamine 
Base 21103-049, Gibco, NY, 
USA 
Fetal Bovine Serum 1% F2442, Sigma, MO, 
USA 
L-glutamine 0.5 mM 25030081, Invitrogen, 
CA, USA 
N2 Supplement 1% 17502-048, Invitrogen, 
CA, USA 
B27 Supplement 2% 17502-044, Invitrogen, 
CA, USA 
Pen Strep 50 units/ml 15140, Gibco, NY, 
USA 





Cell cultures were fixed with -20 ºC 1:1 acetone:methanol for 5 minutes, followed by 
washes in cold 1XPBS. AC3 Rabbit IgG monoclonal primary antibody solution in 
1XPBS ([1:400], 559565, BD-Pharmingen, CA, USA) was incubated with cells overnight 
at 4 ºC. The following day, cells were washed 3 times with 1XPBS and next, they were 
incubated with secondary Donkey anti-rabbit IgG (H+L) AlexaFluor 488nm antibody 
solution ([1:200], A21206, Invitrogen, CA, USA) in the dark. After incubation, cells were 
washed twice with 1XPBS followed by incubation in 40 µg/ml Bisbenzimide H33258 to 
label nuclei for two minutes. After two final washes, chambers from chamber slides were 
removed and slides were coverslipped and sealed with nail polish.  
2-10 Microscopy  
 
 All immunostained tissue and cell cultures were imaged using a Zeiss AxioImager 
Z.1 microscope (Carl Zeiss Microscopy, Jenna, Germany). A Colibri LED light source 
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was the source of the fluorescence (Carl Zeiss Microscopy, Jenna, Germany). Images 
were acquired in 12-bit greyscale using a Zeiss AxioCam MRm camera (Carl Zeiss 
Microscopy, Jenna, Germany) and processing, including false colouring and image 
overlaying, was completed using Zeiss AxioVision v4.8 software (Carl Zeiss 
Microscopy, Jenna, Germany). Figures were compiled with Adobe Photoshop CS5 
Extended 12.0.4 X64 (Adobe Inc, CA, USA) and Microsoft PowerPoint 2016 (Microsoft 
Inc, WA, USA). Contrast and brightness adjustments were applied equally across all 
images.   
2-11 Cell counts 
 
 Cell counts were manually completed using FIJI (Fiji Is Just ImageJ; 
https://fiji.sc/) software (Schindelin et al., 2012). For AC3 counts in forebrain sections, a 
125 µm x 125 µm region of interest (ROI) was placed over the medial portion of the 
medial ganglionic eminence, anterior to the caudal ganglionic eminence and inferior to 
the lateral ganglionic eminence. For AC3 counts of the spinal cord, a 125 µm x 125 µm 
ROI was placed in the dorso-medial cervical spinal cord, which was identified as at the 
level of the cervical enlargement. Cells were defined as apoptotic if they were 
immunopositive for AC3 and had a condensed nucleus, as visualized with Hoechst stain. 
Apoptotic cells were counted out of the total number of Hoechst positive nuclei. For both 
brain and spinal cord counts, three representative regions were counted per embryo. For 
immunocytochemistry, a field of view at 20X was used as the region to count. For each 




2-12 Western blotting 
 
2-12-1 Protein extraction 
 
 Tissue samples were dissected as described above. Samples were kept on ice. 200 
µl of complete immunoprecipitation buffer (complete IP buffer; 25 mM Tris, pH 7.4, 150 
mM NaCl, 1 mM CaCl, 1% Triton X-100 (93426, Sigma, MO, USA), 200 µg/ml 
phenylmethylsulfonyl fluoride (P7626, Sigma, MO, USA), 1µg/ml aprotinin (A-6103, 
Sigma, MO, USA) 1 µg/ml leupeptin (L-2882, Sigma, MO, USA), 1mM dithiothreitol 
(DTT; 43816, Sigma, MO, USA)) was added to each sample. Samples were triturated to 
break up the tissue and incubated on ice for 3 minutes. Samples were triturated until 
milky, which is indicative of complete tissue breakdown, and incubated on ice for 10 
more minutes. Trituration was repeated until samples were completely homogenous. 
Samples were then centrifuged at 2000 rotations per minute (rpm) at 4℃ for 5 minutes 
using an Eppendorf Centrifuge 4417R (Hamburg, Germany) and supernatants were 
transferred to new prechilled microcentrifuge tubes.  
2-12-2 Protein concentration determination 
 
 BioRad Protein Determination Assay reagent (500-0006, BioRad, CA, USA) was 
used to determine the concentration of extracted protein. 5 µl of a 1:5, 1:10 and 1:15 
dilution of protein sample in complete IP buffer was added to 795 µl of ddH2O. 200 µl of 
the BioRad Protein Determination Assay reagent was added to each sample and samples 
were incubated at room temperature before reading absorbance with a Thermo Scientific 
Genesys 10 UV Scanning spectrophotometer (WI, USA) at 595 nm. Sample absorbances 
were compared to a standard curve of Bovine Serum Albumin (BSA; Standard curve 
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from 0-7.5 ug/ml; B4287, Sigma, MO, USA) to interpolate sample protein concentration 
using the following formula: 
 𝑆𝑎𝑚𝑝𝑙𝑒 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 [µ𝑔/µ𝑙] = [
(𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑠𝑎𝑚𝑝𝑙𝑒 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒)
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑆𝑎𝑚𝑝𝑙𝑒(µ𝑙)∗𝑠𝑙𝑜𝑝𝑒
] ∗ 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 
2-12-3 Sample electrophoresis and western blotting 
 
 Prior to western blotting, protein samples were separated via sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE).  For each sample, 35 µg of 
protein was used. The volume of each sample was brought to 20 µl by adding complete 
IP buffer. 5 µl of 5X loading buffer (250 mM Tris-HCl (pH 6.8), 0.5 M DTT, 10% 
Sodium Dodecyl Sulfate (SDS; 15525-017, Invitrogen, CA, USA), 0.5% Bromophenol 
Blue (BPB; B392-5, Fisher Scientific, NJ, USA), 50% Glycerol) was added to each 
sample, and samples were mixed and boiled in a water bath for 5 minutes. Entire sample 
volumes were loaded into a 10% polyacrylamide gel (see Table 2.7 below for gel recipe) 
and were run in a Bio-Rad Mini-PROTEAN® Tetra Cell (1658003, CA, USA) a BioRad 
PowerPac™ Basic Power Supply (1645050, BioRad, CA, USA) at 80 V in running buffer 
(50 mM Tris, 150 mM glycine, 3.5 mM SDS). After samples had passed through the 
stacking gel, the power was increased to 110 V for 2.5 hours. 5 µl of Bio-Rad Precision 
Plus Protein ™ Standards Kaleidoscope™ (#161-0375 Rev B, CA, USA) was run as a 
molecular weight ladder. Protein samples were then transferred from the gel to a 0.2 µm 
nitrocellulose membrane (1620112, Bio-Rad, CA, USA) using a Bio-Rad Mini Trans-
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Blot ® Cell (1703930, BioRad, CA, USA) at 290 mA for 90 minutes in cold transfer 
buffer (25 mM Tris, 150 mM glycine, 20% v/v methanol).  
Table 2.7: SDS PAGE gel recipes 
 10% Separating Gel 4% Stacking Gel 
ddH2O 7.0 ml 4.05 ml 
0.5 M Tris, 1.5 M glycine (pH 8.8) 4.0 ml / 
0.5 M Tris-HCl (pH 6.8) / 1.4 ml 
10% SDS 0.8 ml 0.4 ml 
50% glycerol 2.0 ml 1.0 ml 
40% arcylamide, 0.25% 
bisacrylamide 
5.0 ml (filtered) 1.25 ml (filtered) 
Ammonium persulphate 30 mg in 1 ml ddH2O 25 mg in 1 ml ddH2O 
TEMED 0.02 ml 0.01 ml 
Total volume 20ml 10ml 
 
  
Post-transfer, the membrane was washed in Tween-20 Phosphate Buffered Saline 
(TPBS; 5 mM NaH2PO4, 20 mM Na2HPO4, 154 mM NaCl, 0.1% Tween 20) at room 
temperature 2X 10 minutes. Next, the blot was blocked in 5% blotto (5% skim milk 
powder in TPBS) for 1 hour followed by two washes in 0.5% blotto for 5 minutes each. 
Blot was incubated overnight at 4℃ in primary anti-Mcl-1 antibody ([1:1000]; 600-401-
394, Rockland, PA, USA) in 0.5% blotto. The following day, blots were washed twice in 
0.5% Blotto for 10 minutes each and the appropriate Horse Radish Peroxidase (HRP)-
conjugated secondary antibody (Goat anti-Rabbit IgG HRP conjugate; 1706515, BioRad, 
CA, USA) at [1:2000] in 0.5% Blotto was incubated with the blot for one hour at room 
temperature. Blots were washed in TPBS twice for 10 minutes each and then developed 
with the Western Lightning Plus-ECL Enhanced Chemiluminescence Kit (02118 2512, 
Perkin Elmer Labs Inc., MA, USA) according to manufacturers instructions. Blots were 
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imaged using a GE ImageQuant LAS 4000 (28 9558 10, GE Healthcare, QC, CA). Post-
imaging, blots were stripped of antibodies using Western Blot Stripping Buffer (21059, 
Sigma, ON, CA) at 37℃ for 20 minutes, then washed three times in TPBS for 5 minutes, 
followed by 5 minutes in 0.5% blotto.  Blots were blocked as described, above. Next, 
blots were incubated with anti-β-Actin ([1:5000], A5316, Sigma, ON, CA) in 0.5% blotto 
overnight at 4℃. Blots were washed in 0.5% blotto, incubated in secondary antibody 
(Goat anti-mouse IgG HRP conjugate, 1706516, BioRad, CA, USA), washed in TPBS 
and imaged as described above. β-Actin was used as an internal control for the quantity 
of protein loaded.  
 
2-12-4 Western Analysis 
 
 Western blot band densitometry was performed using FIJI software (Schindelin et 
al., 2012). Background was subtracted with a rolling ball radius of 50px. Band density 
was calculated in arbitrary units (A.U.) and was normalized to β-actin or GAPDH by 
dividing the A.U. of Mcl-1 to the A.U. of β-actin to control for the quantity of protein 
loaded. Normalized values were compared between samples. For Mcl-1, band density 
was calculated as the total density of the doublet of bands observed. For each experiment, 
three blots were analyzed.   
 
2-13 Statistical analysis 
 
All statistical analyses were completed using GraphPad Prism 5.02 (GraphPad 
Software, Inc, CA, USA). Tissue cell counts were analyzed with a parametric one-way 
46 
 
ANOVA with post-hoc analysis using Tukey’s multiple comparison test. In vitro cell 
counts were analyzed with a parametric two-way ANOVA with Bonferroni post-hoc test. 
Western blots comparing control to knockout tissue were analyzed with two-tailed paired 
t-tests, where each control sample was paired with a corresponding knock-out sample run 
in the adjacent lane. For all experiments, a p-value less than 0.05 was considered 

















3-1 Onset of Mcl-1 expression during neurogenesis. 
 
 Expression of Mcl-1 has been shown in the developing nervous system, but only 
at E10, E11.5, and E15.5 (Arbour et al., 2008; Fogarty et al., 2018). These studies 
demonstrated that Mcl-1 was expressed throughout the nervous system in both precursor 
and differentiated populations. Investigation into Mcl-1 expression has shown Mcl-1 is 
expressed in early embryonic tissue up to E6 (Rinkenberger et al., 2000). No study has 
investigated if Mcl-1 is expressed in the early nervous system prior to E10 during 
neurulation. To investigate if Mcl-1 is expressed during early neurulation at E8, a western 
blot for Mcl-1 tissue was performed (Figure 3-1). Although RNA in situ hybridization or 
immunohistochemistry for Mcl-1 would be an appropriate technique, challenges in 
developing protocols that result in a clear Mcl-1 signal have precluded these analyses. 
Heads of E8 wild-type C57Bl/6J embryos were collected and Western analysis was 
performed. E10 and E12 forebrain tissue samples were run as a point of comparison. 
Western blotting for Mcl-1 often results in multiple bands. This has been attributed to 
post-translational proteolytic cleavage of Mcl-1 (Perciavalle et al., 2012; De Biasio et al., 
2007; Huang & Yang-Yen, 2010). Due to challenges dissecting tissue, contamination by 
non-neural tissue was unavoidable. Nonetheless, expression of Mcl-1 was seen in E8 






Figure 3-1. Mcl-1 protein expression is observed at E8. (A) Western blots for Mcl-1 in 
C57BL/6J wild-type E8 embryonic heads compared to E10 and E12 forebrain expression. 
Each E8 head sample contained one pooled litter. Each E10 sample contained 3 pooled 
nervous system samples and each E12 sample contained 2 pooled nervous system 
samples. (B) Densitometry analysis of Mcl-1 protein levels. Mcl-1 protein levels (A.U.) 































3-2 Mcl-1 protein in the Mcl-1 CKO. 
 
 Complete deletion of mcl-1 has been shown in forebrains, brainstems and spinal 
cords in E12 Mcl-1 CKO tissue (Fogarty et al., 2016). The effectiveness of the deletion of 
mcl-1 has not been investigated at prior timepoints. To study the effect of mcl-1 deletion 
during early nervous system development, the effectiveness of the deletion of mcl-1 
needed to be investigated. Protein levels of Mcl-1 in the nervous system of E10 wild-type 
embryos were compared to the nervous system of Mcl-1 CKOs to determine if Mcl-1 was 
effectively excised at the onset of apoptosis. E10 forebrains, brainstems and hindbrains 
were analyzed, separately. (Figure 3-2A; n=3 for each group). Densitometry revealed that 
of the forebrain, brainstem and spinal cord, only the forebrain showed a significant 
decrease in Mcl-1 protein levels [paired t-test t(2)=8.943, p<0.05]. The brainstem and 
spinal cord, however, showed a non-significant decrease (Figure 3-2B; p=0.0733 for 
brainstem and p=0.222 for the spinal cord). None of the knock-out tissue showed a 
complete excision of mcl-1. Challenges in separating the small, delicate E10 nervous 
system from the other developing tissue may have resulted in tissue contamination. The 
tissue of embryos at E10 was softer and the nervous system much smaller than at E12 







Figure 3-2. Mcl-1 protein expression in CTLs compared to Mcl-1 CKOs at E10. (A) 
Western blot analysis of E10 forebrain, brainstem and spinal cord tissue for Mcl-1 protein 
shows that Mcl-1 was reduced but not absent in Mcl-1 CKOs. Each lane represents three 
pooled embryos. β-Actin was used as a control for amount of protein loaded. (B, C, D) 
Densitometry analysis of Mcl-1 doublet to assess protein levels. Mcl-1 protein levels 
were normalized to β-Actin. Control and Mcl-1 CKO protein levels were compared 
separately in E10 (B) forebrain, (C) brainstem and (D) spinal cords using a two-tailed 
paired t-test. Three blots were analyzed for each group.  *p<0.05, Error bars represent +/- 
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3-3 Onset of apoptosis in Mcl-1 CKO forebrains.  
 
The apoptosis that occurs in the forebrain of the Mcl-1 CKO has been 
characterized previously at E12.5 (Arbour et al., 2008); however, the timing of the onset 
of apoptosis has not been identified. In order to investigate the onset of apoptosis in the 
early developing brain of the Mcl-1 CKO, immunofluorescence for AC3 was performed 
on forebrains from E9, E10 and E11 CTL and Mcl-1 CKOs. AC3 immunofluorescence 
showed that endogenous rates of apoptosis were low in control tissue at E9 (n=3), E10 
(n=2) and E11 (n=4) (Figure 3-3B). High magnification revealed full nuclei, as shown by 
Hoechst staining (Figure 3-3B’). Low magnification of Mcl-1 CKOs revealed no 
apoptosis at E9 (n=3), but by E10 (n=2), apoptosis had begun in the developing 
ganglionic eminences of the forebrain. Apoptosis continued in the E11 (n=4) lateral and 
medial ganglionic eminences (Figure 3-3C). Higher magnification of the Mcl-1 CKO 
revealed that at E9, as seen in the lower magnification, no apoptosis was observed, as no 
AC3 staining was present and nuclei were not condensed. The onset of apoptosis was 
observed at E10, with AC3 co-localizing with condensed nuclei, as visualized with 
Hoechst staining. This apoptosis continued at E11 (Figure 3-3C’). This demonstrates that 








Figure 3-3. Apoptosis in the forebrain of E9-E11 Mcl-1 CKOs. (A) Diagram of 
E9-E11 embryos demonstrating the location in the forebrain where AC3 
immunofluorescence was performed. (B) Representative images of active Caspase-3 
(AC3) immunostained (grey) CTL sections from E9, E10 and E11 embryos. (B’) 20X 
magnification of CTL showing Hoechst stained nuclei (grey) and AC3 immunostaining 
(green). (C) Representative images of AC3 immunostained (grey) Mcl-1 CKO sections 
from E9, E10 and E11 embryos (C’) High magnification of Mcl-1 CKO sections showing 
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3-4 Progression of apoptosis in Mcl-1 CKOs brainstem and spinal cord. 
 
 The progression of apoptosis in the Mcl-1 CKO has not been previously 
characterized in the developing brainstem and spinal cord. To address the role of Mcl-1 in 
the developing brain and spinal cord, AC3 immunofluorescence was used as a marker for 
apoptosis in combination with condensed nuclear staining. It was shown that endogenous 
rates of apoptosis were low in littermate control E9 (n=3), E10 (n=2) and E11 (n=4) 
brainstems, upper spinal cords and lower spinal cords (Figure 3-4A). In stark contrast, 
Mcl-1 CKOs showed AC3 immunopositivity beginning at E9 (n=3) in the ventral 
brainstem and rostro-ventral spinal cord, with no AC3 immunopositivity in the caudal 
spinal cord. By E10 (n=2), apoptosis had spread across to encompass the entire 
brainstem, while both the rostral and caudal spinal cords had apoptosis ventrally. At E11 
(n=4), apoptosis still spanned the entire brainstem; however, cells of the more lateral 
regions of the brainstem appeared to be spared as well as a thin region lining the medial 
ventricular surface (Figure 3-4B). This trend was seen again in the upper spinal cord, 
where apoptosis had spread to all but the most dorsal region of the spinal cord and the 
lower spinal cord, where apoptosis had begun to spread dorsally (Figure 3-4B).  
 The conditional deletion of Mcl-1 in the developing nervous system appeared to 
result in apoptosis that began in the rostral region of the brainstem and continued to 
spread caudally from E9 to E11 at each level; moreover, apoptosis spread from ventral to 





Figure 3-4. Apoptosis in the brainstem and spinal cord of Mcl-1 CKO embryos 
progresses in a rostral to caudal manner and within a section, from ventral to dorsal, over 
time. AC3 immunofluorescence (grey) was performed on brainstem and spinal cord 
section from (A) CTL and (B) Mcl-1 CKO littermates at E9, E10 and E11. Arrowheads 
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3-5 Apoptosis that occurs in Mcl-1 CKOs can be rescued through co-deletion of Bax.  
 
 The role that the anti-apoptotic Bcl-2 proteins have in preventing apoptosis is 
through the direct or indirect inhibition of Bax or Bak activation. To better understand the 
molecular pathway through which Mcl-1 inhibits apoptosis during developmental 
neurogenesis, Mcl-1 CKO mice were crossed with the BaxNull line of mice (Knudson et 
al., 1995). Bax was chosen as the likely effector protein responsible for apoptosis in the 
Mcl-1 CKO. Bax is expressed at E6 in early neural tissue whereas Bak is not expressed 
until E12 (Krajewska et al., 2002). The increase in apoptosis in the Mcl-1 CKO was seen 
prior to E12. Furthermore, no gross defects were observed in the nervous system of Bak 
Null mice (Lindsten et al., 2000). To investigate whether the co-deletion of Bax rescued 
apoptosis in the Mcl-1 CKO, the regions with the most extensive apoptosis, the ventral 
forebrain and dorsal spinal cord, were examined.  
3-5-1 Apoptosis that occurs in ventral forebrain of the Mcl-1 CKO can be rescued 
through co-deletion of Bax. 
 
 To determine how Mcl-1 blocks apoptosis in the developing forebrain, 
immunofluorescence for AC3 was performed on E11 Mcl-1 CKO/BaxNull forebrains 
(Figure 3-5-1A). Forebrain sections of the Mcl-1 CKO/BaxNull double knockout 
revealed that co-deletion of Mcl-1 and Bax rescued the apoptosis that occurred in the E11 
ventral forebrain of the Mcl-1 CKO alone. One-way ANOVA analysis of counts of AC3 
immunofluorescence showed a main effect of genotype [F(3,17)=36.45, p<0.0001]. As 
expected, control and mice heterozygous for Mcl-1 and Bax (HET; image not shown) had 
little-to-no endogenous apoptosis in the ventral forebrains at E11 with CTL (n=5) and 
HETs (n=4) averaging 0.02% +/- 0.04% and 0.04% +/- 0.05% AC3 positive cells (Figure 
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3-5-1E). Using Hoechst staining, round, full nuclei could be observed (Figure 3-5-1b). 
Deletion of Mcl-1 in the Mcl-1 CKO (n=5) resulted in a significant increase in apoptosis 
with a mean percent AC3 positive cells of 31% +/- 10% in the ventral forebrain (Figure 
3-5-1E, p<0.0001 compared to CTL, HET and Mcl-1 CKO/BaxNull using Tukey’s 
multiple comparison test). Co-deletion of Mcl-1 and Bax (Mcl-1 CKO/BaxNull; n=4) 
resulted in a complete rescue of apoptosis in the ventral forebrain as seen by a lack of 
AC3 staining (2% +/- 2%; Figure 3-5-1 E), and by the presence of non-condensed, bright 
nuclei (Figure 3-5-1 d). Post-hoc analysis using Tukey’s multiple comparison test showed 
no significant difference between % AC3 positive cells of CTL, HET or Mcl-1 
CKO/BaxNull. The total number of cells within each area was counted and a one-way 












Figure 3-5-1. Co-deletion of anti-apoptotic Mcl-1 and pro-apoptotic Bax rescues the 
apoptosis seen at E11 in Mcl-1 CKOs alone in the ventral forebrain. (A) Diagram of E11 
embryo showing the location of the medial ganglionic eminence and the ROI where 
counts were performed. (B, C, D) Representative ventral forebrain sections where AC3 
immunofluorescence (green) and Hoechst staining (grey) was performed. (B, C, D) 
Higher magnification of the 125µm x 125µm ROI where counts where performed. (B, 
B’) CTL, (C, C’) Mcl-1 CKO, and (D, D’) Mcl-1 CKO/BaxNull. Arrowheads indicate 
where AC3 co-localizes with condensed nuclei (Hoechst). (E) Quantification of percent 
apoptotic cells. (F) Total number of nuclei. Analyses were performed using a one-way 
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3-5-2 Apoptosis that occurs in the dorsal spinal cord of the Mcl-1 CKO can be 
rescued through co-deletion of Bax.  
 
 To determine if Mcl-1 prevents apoptosis through Bax inhibition in the spinal 
cord, apoptosis in Mcl-1 CKO/BaxNull cervical dorsal spinal cords was compared to the 
Mcl-1 CKO (Figure 3-5-2 A). Analysis using a one-way ANOVA of AC3 
immunofluorescence counts combined with Hoechst nuclear staining of E11 spinal cord 
sections revealed a significant main effect of genotype [F (3, 15) = 32.80, p<0.0001]. 
Little apoptosis was observed in CTL (n=4) with mean of 0.06% +/- 0.12% apoptotic 
cells (Figure 3-5-2 B, E) and HET (n=5) with a mean of 0.06% +/- 0.14% apoptotic cells 
(image not shown; figure 3-5-2 E). As expected, Hoechst staining revealed round nuclei 
(Figure 3-5-2 B’). Mcl-1 CKO (n=4) spinal cords had a significant increase in apoptosis 
with a mean of 28% +/- 9.5% (Figure 3-5-2 C, C’, E; p<0.0001 compared to CTL, HET 
and Mcl-1 CKO/BaxNull using Tukey’s multiple comparison test). As with the ventral 
forebrain, Mcl-1 CKO/BaxNull double knock-outs showed a complete rescue of 
apoptosis in the dorsal spinal cord with a mean percent of 1.4% +/- 0.72% apoptotic cells 
(Figure 3-5-2 D, D’, E). Post-hoc analysis using Tukey’s multiple comparison test 
revealed no significant difference in apoptosis in CTL, HET and Mcl-1 CKO/BaxNull. 
One-way ANOVA analysis of the number of nuclei counted showed no significant 
difference between the number of nuclei counted in any of the four genotypes (p=0.3874; 






Figure 3-5-2. Co-deletion of anti-apoptotic Mcl-1 and pro-apoptotic Bax rescues the 
apoptosis seen at E11 in the dorsal spinal cords of Mcl-1 CKOs. (A) Diagram of E11 
embryo showing the location of the dorsal cervical spinal cord and the ROI where counts 
were performed. (B, C, D) Representative dorsal cervical spinal cord sections where AC3 
immunofluorescence (green) and Hoechst staining (grey) were performed. (B’, C’, D’) 
Higher magnification of the 125µm x 125µm ROI where counts were performed. (B, B’) 
CTL, (C, C’) Mcl-1 CKO, and (D, D’) Mcl-1 CKO/BaxNull. Arrowheads indicate where 
AC3 colocalizes with condensed nuclei (Hoechst). (E) Quantification of percent 
apoptotic cells. (F) Total number of nuclei. Analyses were performed using a one-way 




































































3-5-3 Co-deletion of Mcl-1 and Bax does not rescue all apoptosis throughout the 
brainstem and spinal cord of the developing nervous system at E11.  
 
 To determine whether co-deletion of Bax rescued apoptosis throughout the entire 
developing nervous system, AC3 immunofluorescence was performed on brainstem and 
further spinal cord sections (Figure 3-5-3A). This revealed that although apoptosis was 
completely rescued in the dorsal spinal cord at E11 in the Mcl-1 CKO/BaxNull, there 
were regions throughout the developing nervous system that were incompletely rescued. 
Few apoptotic cells were observed in the CTL (n=4) brainstem and spinal cord as 
previously demonstrated. Apoptosis was extensive in the Mcl-1 CKO (n=4), with a dorsal 
to ventral progression across the section and in a rostral to caudal manner. In the Mcl-1 
CKO/BaxNull embryo (n=3), apoptosis appeared to be rescued in the cervical and lumbar 
sections of the spinal cord; however, there were still apoptotic cells in the ventral thoracic 
spinal cord (Figure 3-5-3D’). In the brainstem, most of the apoptosis in the Mcl-1 
CKO/BaxNull co-deletion model was rescued, except in the dorsomedial region (Figure 
3-5-3B’). This suggested that although mcl-1 and bax co-deletion rescued most apoptosis 








Figure 3-5-3. Co-deletion of Mcl-1 and Bax does not rescue all apoptosis throughout the 
developing nervous system at E11. (A-E) Diagram of E11 embryo showing the levels of 
the brainstem and spinal cord where AC3 immunofluorescence (grey) was performed. 
Representative sections of (B’) brainstem, (C’) cervical spinal cord, (D’) thoracic spinal 
cord and (E’) lumbar spinal cord of CTL, Mcl-1 CKO  and Mcl-1 CKO/BaxNull. 























































3-5-4 Apoptosis is rescued throughout the developing brain of E11 Mcl-1 CKO 
embryos when Bax is co-deleted.  
 
 To see if the incomplete rescue in the Mcl-1 CKO/BaxNull model seen in the 
spinal cord was also found throughout the developing brain, AC3 immunostaining of 
brain sections of CTL (n=4), Mcl-1 CKO (n=4), and Mcl-1 CKO/BaxNull (n=4) E11 
brain was performed. In contrast to the brainstem and spinal cord, apoptosis appeared to 
be completely rescued throughout the rostral to caudal regions of the brain. The lateral 
regions of the medial and lateral ganglionic eminence had a few AC3 positive cells, as 
did the dorsal-medial forebrain (Figure 3-5-4C), which may indicate a lack of complete 
rescue, but no region appeared to have any large clustering of apoptotic cells as observed 
in the brainstem and spinal cord (Figure 3-5-3). This indicated that throughout the 












Figure 3-5-4. Apoptosis is rescued throughout the developing brains of E11 Mcl-1 CKO 
embryos when Bax is co-deleted. E11 brain sections of (A) CTL (B) Mcl-1 CKO and (C) 
Mcl-1 CKO/BaxNull immunostained for AC3 (grey). Arrowheads indicate regions where 
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3-6 Apoptosis in differentiating Mcl-1 CKOs was rescued through co-deletion of Bax 
in vitro. 
 
 The in vivo results show apoptosis in the Mcl-1 CKO begins with the onset of 
neurogenesis, when differentiation begins. I next investigated whether NPCs became 
dependent on Mcl-1 for survival as they differentiate in vitro. To address this, 
neurospheres were induced to differentiate for 1, 3 or 7 days. Immunocytochemistry for 
AC3 was performed and apoptotic cells were counted (Figure 3-7A). Using a two-way 
ANOVA, a significant main effect of interaction was found [F (6,45) = 3.949, p<0.01], a 
main effect of genotype was found [F (3,45) = 24.19, p<0.0001], but no main effect of 
time (p=0.3954) was found. Bonferroni post-hoc analysis at day 1 revealed Mcl-1 CKOs 
had significantly more apoptosis compared to both BaxNull (p<0.05) and Mcl-1 
CKO/BaxNull (p<0.05). There was no significant difference between CTL and BaxNull, 
Mcl-1 CKO or Mcl-1 CKO/BaxNull. At day 3 Mcl-1 had significantly more apoptosis 
than BaxNull (p<0.01). There was no significant difference between CTL and either 
BaxNull, Mcl-1 CKO or Mcl-1 CKO/BaxNull. Increased apoptosis was observed in Mcl-
1 CKOs at day 7 compared to CTL (p<0.001) and BaxNull cells (p<0.001), and this 
increase was abolished when bax was co-deleted (Figure 3-7B; p<0.001). This showed 
that NPCs are dependent on Mcl-1 for survival in vitro as they differentiate and that co-







Figure 3-6. Differentiation of neurospheres in vitro causes apoptosis in Mcl-1 CKOs and 
this is rescued in Mcl-1 CKO/BaxNulls. Neurospheres were cultured from E11 forebrains 
for 3 days in vitro before differentiating. (A) Representative images of day 7 in vitro 
differentiated neurospheres reveal increases in AC3 staining (green) in Mcl-1 CKOs 
compared to CTLs was rescued in the Mcl-1 CKO/BaxNull double knock-out. White 
arrowheads indicate examples of AC3 staining. Hoechst staining shows nuclei (grey). (B) 
Quantification of percent AC3 positive cells. Statistical analysis was carried out using a 












3-7 Co-deletion of Mcl-1 and Bax was embryonic lethal in one transgenic model, but 
not another.  
 
 Mcl-1 CKOs have been found to be lethal by E15.5 (Arbour et al., 2008). As the 
Mcl-1 CKO/BaxNull rescued the majority of apoptosis associated with Mcl-1 CKO 
alone, the survival rate of these embryos was investigated to see if the double knockout 
rescued the embryonic lethality. As shown in Table 3.1, at E11 the Mcl-1 CKO/BaxNull 
co-deletion model survives at a rate predicted by Mendelian genetics, but it is embryonic 
lethal by E13. In contrast, when Mcl-1 CKO mice containing one floxed allele of bax and 
one null allele of bax (NesCre:Mcl-1f/-:Baxf/-; Mcl-1 CKO/BaxNull:Floxed) were 
generated, they survived to at least postnatal day 18 (P18). P18 was the latest timepoint 





Table 3.2: Recovery of Mcl-1 CKO/BaxNull:Floxed embryos. 





The experiments performed in this thesis investigated the anti-apoptotic role that 
Mcl-1 has in the formation of the early murine nervous system in utero. Using the Mcl-1 
CKO model, several novel functions of Mcl-1 have been elucidated. First, Nestin:Cre-
mediated mcl-1 deletion resulted in apoptosis throughout the forebrain, brainstem and 
spinal cord of the developing nervous system. Second, co-deletion of mcl-1 and bax 
revealed that the pro-survival role of Mcl-1 is largely through pro-apoptotic Bax in both 
the forebrain and spinal cord. Last, in vitro modeling of NPCs using neurospheres 
showed differentiating NPCs depend on Mcl-1 for survival. Collectively, these results 
suggest a pan-nervous system dependency on Mcl-1 during development for survival 
through inhibition of pro-apoptotic Bax.  
4-1 Dependency on Mcl-1 is widespread in the developing nervous system. 
 
Mcl-1 expression has been found in the early implanting embryo, with expression 
peaking at E5, and decreasing slightly at E6.5 (Rinkenberger et al., 2000). Germline 
deletion of mcl-1 is preimplantation lethal at E3.5-E4, suggesting a critical role for Mcl-1 
in early embryonic development (Rinkenberger et al., 2000). Expression of Mcl-1 has 
also been found at E10, E11.5, E12 and E15.5 in the developing forebrain (Arbour et al., 
2008; Fogarty et al., 2018). No study has investigated the onset of Mcl-1 expression in 
the developing nervous system. Formation of the neural tube from the neural plate begins 
at E8, so this time point was investigated to determine if Mcl-1 expression was present in 
the early developing nervous system (Copp et al., 2003). As Mcl-1 is found in the embryo 
at E6 and E10, it was hypothesized that Mcl-1 protein is expressed in between these 
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timepoints. Western blot analysis revealed Mcl-1 is expressed at E8 in the embryonic 
heads. Due to the small size of the E8 embryo, contaminating tissue from outside of the 
nervous system prevents a conclusive argument that Mcl-1 is present at E8 in the 
developing nervous system. A lack of an effective antibody or riboprobe for tissue 
histology limits the analysis to Western blotting.    
  The complete deletion of Mcl-1 in the Mcl-1 CKO model used in this thesis has 
been shown in the E12 forebrain, brainstem and spinal cord, but not at an earlier 
timepoint (Fogarty et al., 2018). As the aims of this thesis were to investigate the role 
Mcl-1 plays in the survival of the early nervous system, the effective deletion of Mcl-1 at 
earlier timepoints needed to be addressed. The Mcl-1 CKO uses Nestin-mediated:Cre to 
selectively delete both alleles mcl-1 in NPCs (Arbour et al., 2008). Expression of Nestin 
begins at E7.5 and can be found in proliferating populations throughout the early nervous 
system, apart from the olfactory epithelium and hippocampal granule neuron progenitor 
populations (Dahlstrand et al., 1995; Kawaguchi et al., 2001). Effective Cre expression in 
the Nestin:Cre embryo has been shown using β-galactosidase staining of a Rosa LacZ 
reporter mouse at E12.5 (Bérubé et al., 2005); however, deletion of mcl-1 prior to E12 
has not been examined in the Mcl-1 CKO. Western blot analysis of E10 Ctl vs Mcl-1 
CKO forebrain, brainstem and spinal cord show that only in the forebrain is Mcl-1 
significantly reduced, although a non-significant, trending decrease is observed with the 
brainstem and spinal cord. As with the E8 nervous system tissue, limitations in the 
dissection cannot preclude contaminating, non-neural tissue. Another limitation could be 
the small sample size. As there was a strong trend towards a decrease in Mcl-1 in the 
brainstem, increasing the sample size could have resulted in significance.  
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 Cre inducible deletion is not always complete (Chen et al., 2016; Liang et al., 
2012). The Nestin:Cre mice in the study were developed by Bérubé et al (2005). Cre 
expression was shown by E12 in these mice. Although it is plausible that Mcl-1 is not 
completely knocked out at E8-E11, it has been shown that Mcl-1 is completely knocked-
out in forebrains, brainstems and spinal cords of mice at E12, suggesting the deletion of 
Mcl-1 in the nervous system is complete (Fogarty et al., 2018). One limitation of this 
study is that complete deletion of a gene using Nestin:Cre has not been shown at a 
timepoint earlier than E12. 
The Mcl-1 CKO has previously been shown to result in embryonic lethality by 
E15.5 (Arbour et al., 2008). Apoptosis in the Mcl-1 CKO has been found in the 
developing forebrain at E12.5 and was observed in Nestin+ NPCs, Doublecortin+ 
migrating neuroblasts and Tuj1+ newly born neurons (Arbour et al., 2008). Apoptosis 
prior to E12.5 in the forebrain had not been investigated. Apoptosis was first seen in the 
ventral forebrain at E10, but not prior, at E9.  This indicates that, in the Mcl-1 CKO, 
apoptosis initiates in ventral forebrain at E10. This region of the forebrain consists of the 
early medial and lateral ganglionic eminences, which contain precursors to the subpallial 
regions of the brain, as well as cortical GABAergic interneuron precursors (Lavdas et al., 
1999; Turrero Garcia & Harwell, 2017). The continued widespread apoptosis in the 
ventral E11 forebrain suggests that many precursor populations are dependent on Mcl-1 
for survival.  
The dependency of precursor populations on Mcl-1 within the developing 
brainstem and spinal cord has not previously been investigated. Apoptosis started in the 
ventral brainstem at E9 and then, over time from E9 to E11, spreads across two axes, 
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from ventral to dorsal as well as from rostral to caudal. This progression closely mirrors 
the differentiation of the developing spinal cord and brainstem. Differentiation in the 
developing spinal cord begins ventrally and progresses dorsally (McConnell, 1981). 
Further, rostral signalling with RA from the somatic mesoderm causes cells of the 
developing neural tube to differentiate, whereas caudal Wnt and Fgf signalling prevents 
differentiation. This results in a progression of differentiation that begins rostrally and 
progresses caudally over time (Gouti et al., 2015). The similarity between the progression 
of apoptosis in the Mcl-1 CKO and the progression of differentiation in the developing 
spinal cord suggests that NPCs in the developing nervous system may become dependent 
on Mcl-1 as they differentiate. Mcl-1 has been shown to be an important survival factor 
as NPCs of the developing forebrain differentiate into immature neurons (Arbour et al., 
2008). Further, Mcl-1 has been identified as an important factor in the terminal mitosis of 
NPCs as they differentiate into post-mitotic neurons (Hasan et al., 2013).  
Patterning of the spinal cord begins at E9.5 and the many types of neurons within 
the adult spinal cord are derived from twelve basic progenitor cell types (Alaynick et al., 
2011). The progression of apoptosis in the Mcl-1 CKO across the developing spinal cord 
and brainstem appears to affect most cell populations showing that many precursor 
populations are dependent on Mcl-1 for survival. Interestingly, apoptosis does not occur 
immediately adjacent to the midline of the spinal cord and brainstem. The midline is 
where actively dividing cells are located, and previous research in the forebrain has 
shown that Phospho-Histone H3 positive cells, cells that are in mitosis, do not change in 
number in the Mcl-1 CKO (Arbour et al., 2008). Another region spared from apoptosis is 
the ventral horns of the developing spinal cord. Although not quantified, some cells in the 
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ventral horns at E11 undergo apoptosis in the Mcl-1 CKO, but most cells are spared. The 
ventral horns contain motor neurons. This region has been shown to be dependent on Bcl-
xL, another anti-apoptotic Bcl-2 family member that may compensate for the loss of Mcl-
1 in the Mcl-1 CKO (Fogarty et al., 2018; Fogarty et al., 2016).  
An interesting observation in the Mcl-1 CKO is that the early nervous system still 
forms. This implies that the early nervous system is not dependent on Mcl-1 for survival 
and that NPCs in the developing nervous system acquire a dependency on Mcl-1.  
The absence of Mcl-1 appears to trigger apoptosis without any additional 
stimulus. This suggests that NPCs of the developing nervous system are primed to die. 
These cells may require constant pro-survival signalling to prevent apoptosis. It has been 
observed that human embryonic stem cells are primed to die, as well, with a large amount 
of pro-apoptotic PUMA being expressed and relatively lower expression of anti-apoptotic 
Bcl-2. This primed state is not observed in more differentiated cells (Geijsen, 2013; Liu 
et al., 2013). This could be the case with the cells of the nervous system, where a large 
amount of pro-apoptotic signalling is constantly present in NPCs. As was seen in the 
differentiating embryonic stem cells, as NPCs differentiate into mature neurons, their 
dependency on Mcl-1 is not anti-apoptotic in nature, and deletion of mcl-1 no longer 
results in increased apoptosis, but autophagy (Germain et al., 2011). Mature, adult 
neurons become resistant to apoptosis partially through inhibition of PUMA and BIM by 
microRNAs as well as inhibition of APAF1, increased expression of XIAP and decreased 




4-2 Mcl-1 exerts its pro-survival function through inhibition of Bax activation.  
 
 
The Bcl-2 family contains pro-apoptotic and anti-apoptotic members that act to 
inhibit each other. The BH3-only proteins act as sensors, detecting damage and death 
signals within the cell. Upon activation, they activate the effector proteins Bax and/or 
Bak. The anti-apoptotic Bcl-2 family members, including Mcl-1, inhibit both the BH3-
only members and the effector proteins (Youle & Strasser, 2008). No research has 
elucidated the pro-apoptotic effector protein that Mcl-1 acts to inhibit in the developing 
nervous system. There are two pro-apoptotic effector proteins, Bax and Bak. Bax was the 
first candidate as it has been associated with being inhibited by Mcl-1 (Germain et al., 
2008). Further, Bax has been shown to be important in promoting cellular death in 
nervous system development (Deckwerth et al., 1996; Vekrellis et al., 1997). In contrast, 
Bak deficient mice have not been shown to have gross nervous system dysfunction 
(Lindsten et al., 2000).  A co-deletion model of Mcl-1 and Bax was generated by crossing 
the Mcl-1 CKO onto a BaxNull line of mice. Of note, there was no significant differences 
in the number of nuclei in the CTL, Mcl-1 CKO, and Mcl-1 CKO/BaxNull. This means 
the apoptosis in the Mcl-1 CKO was recent, as there had not been time to clear the nuclei 
that have condensed as the cells underwent apoptosis (Bursch et al., 1990). Apoptosis in 
the Mcl-1 CKO is rescued through co-deletion of bax in both the ventral forebrain and the 
dorsal cervical spinal cord. Observations of the entire spinal cord and forebrain reveal 
that although most of the apoptosis in the Mcl-1 CKO/BaxNull mouse model is rescued 
compared to the Mcl-1 CKO alone, certain regions appear to not be rescued. These 
regions contain clustering of AC3 positive cells within the dorso-medial brainstem and 
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the ventral lumbar region of the spinal cord. The brain of the double knockout does not 
contain any large clustering of AC3 positive cells, but a few are found in the lateral 
regions of the medial and lateral ganglionic eminences. These regions of incomplete 
rescue may be dependent on Mcl-1 directly or indirectly interacting with Bak to prevent 
apoptosis.  
 The complete pathway of how Mcl-1 inhibits apoptosis has yet to be elucidated; 
however, the experiments presented show that Mcl-1 acts to prevent Bax from initiating 
apoptosis, whether it be direct or indirect. Mcl-1 could directly interact with Bax, or it 
could bind and inhibit a BH3-only protein. Whether inhibited directly or indirectly, Bax 
needs to be activated by a BH3-only protein to initiate apoptosis (Youle & Strasser, 
2008). The candidates through which Mcl-1 inhibits Bax are the BH3-only proteins. To 
prevent the activation of Bax, Mcl-1 would need to prevent a direct-activator BH3-only 
protein from binding and activating Bax. The two direct activators that have been shown 
to interact with Mcl-1 are Bim and PUMA (Shamas-Din et al., 2013). Previous data from 
our lab suggests that Bim expression is high in the developing nervous system, making it 
the likely candidate, yet co-deletion of Mcl-1 and Bim in T-lymphocytes was unable to 
rescue the apoptosis induced by deletion of Mcl-1 alone (Tripathi et al., 2013). An 
alternative hypothesis is that Mcl-1 blocks both Bim and PUMA in the T-lymphocytes, 
and this could be true for the developing nervous system as well. Co-deletion of Bim and 
Bcl-xL rescues the apoptosis associated with deletion of Bcl-xL alone in hematopoietic 
cells but does not rescue apoptosis in the developing nervous system, suggesting that 
more pro-apoptotic proteins may be important in the nervous system (Akhtar et al., 
2008). PUMA has been found to be important for promoting death after gamma 
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irradiation in the adult brain (Jeffers et al., 2003). In embryonic NPCs, PUMA deletion 
prevents death due to genotoxic stress (Akhtar et al., 2006). These findings suggest that 
PUMA is at least partially responsible for apoptosis in the nervous system, although 
future studies would be required to determine if Mcl-1 is responsible for inhibiting the 
pro-apoptotic activity of PUMA.   
 
4-3 in vitro analysis reveals the pro-survival role of Mcl-1 may vary depending on 
the state of differentiation.   
 
 
 In vitro analysis of primary cell cultures allows more precise control over the 
conditions in which cells grow. Using neurosphere cultures derived from NPCs of the 
developing E11 forebrain, one can maintain cells in a proliferative state and inhibit 
differentiation from occurring (Reynolds & Weiss, 1992). Upon coating the cell culture 
dishes and the addition of a differentiating media containing FBS, neurospheres begin to 
adhere to the dish and differentiate. In Mcl-1 CKO differentiating neurospheres, it took 
seven days for apoptosis to significantly increase. This suggests that as NPCs 
differentiate, they acquire a dependency on Mcl-1 for survival.  
The 7 days it took for apoptosis to occur in the differentiating Mcl-1 CKOs could 
be due to cells lifting off as they undergo apoptosis. At earlier timepoints, when the 
neurospheres are less differentiated, they are less adhered to the culture dishes. Cells 
naturally lift off dishes and separate from other cells when they undergo apoptosis. As 
cells differentiate, they become more adherent to the dish. Cells undergoing apoptosis 
prior to day 7 may lift off faster and wash away during immunocytochemistry, artificially 
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masking an increase in apoptosis at earlier timepoints. Importantly, however, the Mcl-1 
CKO/BaxNull co-deletion model was able to rescue the increased apoptosis seen in the 




4-4 Co-deletion of Mcl-1 and Bax was embryonic lethal in one transgenic model, but 
not in another. 
 
 The co-deletion of Mcl-1 and Bax rescued apoptosis but did not initially appear to 
rescue embryonic lethality. This was using the Mcl-1 CKO/BaxNull mouse line 
(Nes:Cre+/-:Mcl-1f/f:Bax-/-) where there is embryonic lethality prior to E13. This is 
unusual as the Mcl-1 CKO is embryonic lethal at E15.5 (Arbour et al., 2008) and Bax 
Null mice are not embryonic lethal, but instead survive to adulthood (Knudson et al., 
1995). When one Bax Null allele was switched for a Bax floxed allele (Nes:Cre+/-:Mcl-
1f/f:Bax-/f) however, the embryonic lethality was rescued and pups survived beyond birth 
to, at least, postnatal day 18. It is counterintuitive that swapping a single Bax Null allele 
with a Bax floxed allele would rescue the embryonic lethality. Other unknown genetic 
defects in the transgenic line could be to blame for the inability of the Mcl-1 
CKO/BaxNull mice to survive to birth.  
4-5 Future directions 
 
 The work presented highlights the role that Mcl-1 plays in the early development 
of the nervous system; however, more experiments are needed to fully understand the 
role of Mcl-1 in neurogenesis.  
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Firstly, Mcl-1 expression appears to begin early in nervous system development 
and yet deletion of Mcl-1 still results in the formation of a neural tube and primitive 
nervous system. Future experiments are needed to spatially resolve the expression of 
Mcl-1 in the nervous system and more clearly determine the extent of the deletion of 
Mcl-1 in the Mcl-1 CKO. Although the compensatory roles between Bcl-xL and Mcl-1 
have been discovered in the nervous system as NPCs proliferate and differentiate, these 
roles occur after the neural tube forms (Fogarty et al., 2018). Thus, there may be 
redundancy with other anti-apoptotic proteins in the developing neural tube. The 
development of an effective antibody against Mcl-1 or a riboprobe for RNA in situ 
hybridization would allow for the proper spatial resolution of Mcl-1 expression in the 
developing nervous system. 
Mcl-1 inhibits apoptosis through pro-apoptotic effector protein Bax; however, it is 
unclear through which mechanism this occurs. The likely candidate is pro-apoptotic Bim, 
as discussed above, but more work is needed to elucidate the exact pathway through 
which this occurs. Whether multiple BH3-only proteins are inhibited by Mcl-1 in the 
developing nervous system remains to be elucidated. Further, yet unknown pro-apoptotic 
proteins may be inhibited by Mcl-1. Although most of the cell death appears to be 
mediated through Bax, small regions in the brainstem and ventral thoracic spinal cord 
appear to undergo apoptosis in the absence of Bax. Future expression studies could 
determine if apoptosis is mediated by pro-apoptotic Bak in these regions.  
Lastly, the successful rescue of embryonic lethality using the Mcl-1 
CKO/BaxNull;floxed model provides an excellent system to understand the role that Mcl-
1 plays in developmental neurogenesis. As previous research has shown that the 
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overexpression of Mcl-1 results in premature terminal mitosis (Hasan et al., 2013), it can 
be hypothesized that the deletion of Mcl-1 will result in a reduction in differentiation of 
NPCs in the developing brain. As neurogenesis does not begin until E11, the Mcl-1 
CKO/BaxNull model, which is embryonic lethal by E13, is not effective at investigating 
the roles that Mcl-1 plays in differentiation. Identifying if the postnatal brain of the Mcl-1 
CKO/BaxNull;floxed model has more NPCs and fewer differentiated neurons, or 
alternatively, if the double knockout has fewer early born neurons and more late born 
neurons would shed light on the role that Mcl-1 plays in cell-cycle exit and 




 Here, the role that Mcl-1 plays in developmental neurogenesis was investigated. 
Two specific aims were addressed. First, the progression of apoptosis in the Mcl-1 CKO 
was investigated. The deletion of Mcl-1 results in apoptosis starting at E10 in the ventral 
forebrain and at E9 in the brainstem and spinal cord. Apoptosis in the brainstem and 
spinal cord progressed dorsally and caudally over time, similar to the progression of 
differentiation. Then, using a co-deletion model of mcl-1 and bax, it was shown that Mcl-
1 inhibits cell death in the developing nervous system through the inhibition of Bax. 
Lastly, although the Mcl-1 CKO/BaxNull co-deletion model was lethal by E13, another 
model, the Mcl-1 CKO/BaxNull;Floxed model, did rescue the embryonic lethality 
induced by Mcl-1 CKO alone.  
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 In summary, the much of the early nervous system is dependent on Mcl-1 for 
survival and this is mediated largely through the inhibition of pro-apoptotic Bax. Future 
studies investigating the role that Mcl-1 plays in cell cycle exit are now possible due to 
the development of a double knockout model that rescues the cell death and embryonic 
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6.0 Appendix A 
 
Table 6.1: Probability of each genetic cross when breeding to obtain an Mcl-1 CKO. 
Cross: ♂ Nes:Cre+/- Mcl-1+/-  X             ♀ Mcl-1-/- 
Probability Phenotype Genotype 
1/4 Mcl-1 CKO Nes:Cre+/- Mcl-1-/- 
1/4 Mcl-1 Het Nes:Cre+/- Mcl-1+/- 




Table 6.2: Probability of each genetic cross when breeding to obtain an Mcl-1 
CKO/BaxNull. 
Cross: ♂ Nes:Cre+/- Mcl-1+/- Bax+/- X         ♀ Mcl-1-/- Bax+/- 
Probability Phenotype Genotype 
1/16 Mcl-1 CKO/BaxNull Nes:Cre+/- Mcl-1-/- Bax-/- 
1/8 Mcl-1 CKO/BaxHet Nes:Cre+/- Mcl-1-/- Bax+/- 
1/16 Mcl-1 Het/BaxNull Nes:Cre+/- Mcl-1+/- Bax-/- 
1/8 Mcl-1 Het/Bax Het Nes:Cre+/- Mcl-1+/- Bax+/- 
1/16 Mcl-1 CKO Nes:Cre+/- Mcl-1-/- Bax+/+ 
1/16 Mcl-1 Het Nes:Cre+/- Mcl-1+/- Bax+/+ 
1/8 Bax Null Mcl-1+/- Bax-/- 
Mcl-1-/- Bax-/- 
1/4 Bax Het Mcl-1+/- Bax+/- 
Mcl-1-/- Bax+/- 
1/8 Ctl Mcl-1+/- Bax+/+ 
Mcl-1-/- Bax+/+ 
 
  
 
